| Literature DB >> 30184501 |
Hanna Shin1, Rebecca E W Kaplan2, Tam Duong1, Razan Fakieh1, David J Reiner3.
Abstract
C. elegans vulval precursor cell (VPC) fates are patterned by an epidermal growth factor (EGF) gradient. High-dose EGF induces 1° VPC fate, and lower dose EGF contributes to 2° fate in support of LIN-12/Notch. We previously showed that the EGF 2°-promoting signal is mediated by LET-60/Ras switching effectors, from the canonical Raf-MEK-ERK mitogen-activated protein (MAP) kinase cascade that promotes 1° fate to the non-canonical RalGEF-Ral that promotes 2° fate. Of oncogenic Ras effectors, RalGEF-Ral is by far the least well understood. We use genetic analysis to identify an effector cascade downstream of C. elegans RAL-1/Ral, starting with an established Ral binding partner, Exo84 of the exocyst complex. Additionally, RAL-1 signals through GCK-2, a citron-N-terminal-homology-domain-containing MAP4 kinase, and PMK-1/p38 MAP kinase cascade to promote 2° fate. Our study delineates a Ral-dependent developmental signaling cascade in vivo, thus providing the mechanism by which lower EGF dose is transduced.Entities:
Keywords: EXOC-8; Happyhour; MAP4K; MIG-15; MLK-1; Misshapen; RLBP-1; RalBP1; SEC-5; Sec5
Mesh:
Substances:
Year: 2018 PMID: 30184501 PMCID: PMC6484852 DOI: 10.1016/j.celrep.2018.08.011
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423